Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation
Alimentary Pharmacology & Therapeutics2015Vol. 43(1), pp. 61–72
Citations Over TimeTop 10% of 2015 papers
A. J. F. Coimbra, Jordi Rimola, S. O’Byrne, Timothy T. Lu, T. Bengtsson, Alex de Crespigny, Diana Luca, P. Rutgeerts, David H. Bruining, Jeff L. Fidler, W. J. Sandborn, Cynthia Santillan, Peter Higgins, Mahmoud M Al-Hawary, Séverine Vermeire, Dirk Vanbeckevoort, Ragna Vanslembrouck, Laurent Peyrin‐Biroulet, V. Laurent, Karin A. Herrmann, Julián Panés
Abstract
Magnetic resonance enterography of high-quality and reproducibility was feasible in a global multi- centre setting, with evidence for improved selectivity over CDAI and ileocolonoscopy in identifying appropriate CD patients for inclusion in therapeutic intervention trials.
Related Papers
- → A Cross-sectional literature survey showed the reporting quality of multicenter randomized controlled trials should be improved(2021)16 cited
- → Statistical issues relating to international differences in clinical trials(2001)27 cited
- → Single-center versus multicenter trials(1986)13 cited
- → German Multicenter Studies on Plateletpheresis from Healthy Donors(1993)1 cited
- Efficacy and Safety of virtual reality in Stroke Rehabilitation: a multicenter randomized trial (EVREST Multicenter)(2016)